Data di Pubblicazione:
2021
Citazione:
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure / Bhatt, Deepak L; Szarek, Michael; Steg, P Gabriel; Cannon, Christopher P; Leiter, Lawrence A; Mcguire, Darren K; Lewis, Julia B; Riddle, Matthew C; Voors, Adriaan A; Metra, Marco; Lund, Lars H; Komajda, Michel; Testani, Jeffrey M; Wilcox, Christopher S; Ponikowski, Piotr; Lopes, Renato D; Verma, Subodh; Lapuerta, Pablo; Pitt, Bertram. - In: THE NEW ENGLAND JOURNAL OF MEDICINE. - ISSN 0028-4793. - (2021). [10.1056/NEJMoa2030183]
Abstract:
Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure or death from cardiovascular causes among patients with stable heart failure. However, the safety and efficacy of SGLT2 inhibitors when initiated soon after an episode of decompensated heart failure are unknown.
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Bhatt, Deepak L; Szarek, Michael; Steg, P Gabriel; Cannon, Christopher P; Leiter, Lawrence A; Mcguire, Darren K; Lewis, Julia B; Riddle, Matthew C; Voors, Adriaan A; Metra, Marco; Lund, Lars H; Komajda, Michel; Testani, Jeffrey M; Wilcox, Christopher S; Ponikowski, Piotr; Lopes, Renato D; Verma, Subodh; Lapuerta, Pablo; Pitt, Bertram
Link alla scheda completa:
Pubblicato in: